Back
Berkshire Hathaway, Inc. Vs. Axsome Therapeutics, Inc. Industry Stock Comparison
Sell
49
BRK.A
Berkshire Hathaway, Inc.
Last Price:
$753,731.01
Seasonality Move:
6.5%
Buy
75
AXSM
Axsome Therapeutics, Inc.
Last Price:
$182.74
Seasonality Move:
22.61%
Sell
49
Berkshire Hathaway, Inc. (BRK.A)
is a Sell
Is Berkshire Hathaway, Inc. a Buy, Sell or Hold?
-
The current Berkshire Hathaway, Inc. [BRK.A] share price is $754,800.00. The Score for BRK.A is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Axsome Therapeutics, Inc. (AXSM)
is a Buy
Is Axsome Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Axsome Therapeutics, Inc. [AXSM] share price is $182.64. The Score for AXSM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BRK.A Stock Price Chart
What is Berkshire Hathaway, Inc.'s stock price today?
-
The Berkshire Hathaway, Inc. share price today is $754,800.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRK.A is experiencing slight selling pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics, Inc.'s stock price today?
-
The Axsome Therapeutics, Inc. share price today is $182.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
BRK.A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 674.89 | Buy |
| Relative Strength Index (14 RSI): | 53.21 | Buy |
| Chaikin Money Flow: | -142 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (753006.23 - 753022.23) | Buy |
| Bollinger Bands (100): | (743148.84 - 743174.84) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.73 | Buy |
| Relative Strength Index (14 RSI): | 79.74 | Buy |
| Chaikin Money Flow: | 2638953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.49 - 157.75) | Buy |
| Bollinger Bands (100): | (116.98 - 146.48) | Buy |
BRK.A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 750826.34 | Buy |
| 20-day SMA: | 750156.48 | Buy |
| 50-day SMA: | 747185.3 | Buy |
| 200-day SMA: | 747227.11 | Buy |
| 8-day EMA: | 752201.74 | Buy |
| 20-day EMA: | 751506.92 | Buy |
| 50-day EMA: | 748775.57 | Buy |
| 200-day EMA: | 736008.79 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 156.17 | Buy |
| 20-day SMA: | 151.07 | Buy |
| 50-day SMA: | 144.32 | Buy |
| 200-day SMA: | 119.69 | Buy |
| 8-day EMA: | 157.9 | Buy |
| 20-day EMA: | 152.42 | Buy |
| 50-day EMA: | 144.44 | Buy |
| 200-day EMA: | 123.72 | Buy |
Berkshire Hathaway, Inc. Earnings Growth & BRK.A Earnings Dates
-
Analysts estimate an earnings increase this quarter of $299.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,470.08 per share, and a decrease next year of $2,259.18 per share.
Axsome Therapeutics, Inc. Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.11 per share, and an increase next year of $5.92 per share.
Berkshire Hathaway, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||